Publications
- Thrombosis in thrombocythemic Ph- myeloproliferations is associated with higher platelet count prior to the event: results of analyses of prothrombotic risk factors from a registry of patients treated with anagrelide2016 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Second Faculty of Medicine
- Current survival measures reliably reflect modern sequential treatment in CML: Correlation with prognostic stratifications2013 | Third Faculty of Medicine, Faculty of Medicine in Pilsen
- Evaluation of 5-year imatinib treatment of 458 patients with CP-CML in routine clinical practice and prognostic impact of different BCR-ABL cutoff levels2013 | Central Library of Charles University, Faculty of Medicine in Pilsen
- Efficacy and tolerance of dasatinib after imatinib failure or intolerance for patients with chronic myeloid leukemia treated in three different hospitals compare well with results achievable in formal clinical trials2013 | Publication without faculty affiliation
- Current treatment of chronic myeloid leukemia - tyrosinkinas inhibitors.2012 | First Faculty of Medicine
- Treatment of consecutive patients with chronic myeloid leukaemia in the cooperating centres from the Czech Republic and the whole of Slovakia after 2000 - a report from the population-based CAMELIA registry2011 | Faculty of Medicine in Hradec Králové, Central Library of Charles University, First Faculty of Medicine, Third Faculty of Medicine
- Telomere length, molecular cytogenetic findings, and immunophenotypic features in previously untreated patients with B-chronic lymphocytic leukemia2010 | First Faculty of Medicine
- Prolymphocytic leukemia +22010 | First Faculty of Medicine
- Anagrelide in the treatment of essential thrombocythemia2004 | First Faculty of Medicine
- Imatinib (Glivec) in the treatment of patients with accelerated phase of chronic myelogenous leukaemia and Ph-positive acute lymphoblastic leukemia2003 | First Faculty of Medicine
Loading network view...